For the quarter, this represents 1% of our outstanding shares With 60% of our outstanding shares repurchased since Allison's IPO in 2012, we ended the quarter net leverage ratio of 2.2x, $344,000,000 of cash $644,000,000 Available revolving credit facility commitments. In addition, we continue to maintain a flexible long dated and covenant light debt structure With the earliest maturity due in 2026, over $2,500,000,000 of outstanding debt, 623,000,000 dollars is subject to variable interest rates, of which $550,000,000 is hedged, resulting in 95% of our debt being fixed through the Q3 of 2025. Please turn to Slide 9 of the presentation for the update to our 2023 guidance. Given Q1 2023 results and current end market conditions, we are raising our full year At the midpoint, this represents over 6% year over year growth based on continued strength in demand in our end markets, Price increases on certain products and the continued execution of growth initiatives leading to another anticipated record net sales year. In addition to Allison's 2023 net sales guidance, we anticipate net income in the range of $550,000,000 to $600,000,000 Adjusted EBITDA in the range of $1,010,000,000 to $1,090,000,000 Net cash provided by operating activities in the range of $635,000,000 to $695,000,000 Capital expenditures in the range of $125,000,000 to $135,000,000 and adjusted free cash flow in the range of $510,000,000 to $560,000,000 This concludes our prepared remarks.